Suppr超能文献

2022年波兰针对严重急性呼吸综合征冠状病毒2的分子诊断工具

Molecular Diagnostic Tools against SARS-CoV-2 in Poland in 2022.

作者信息

Fulawka Lukasz, Kuzan Aleksandra

机构信息

Molecular Pathology Centre Cellgen, 50-353 Wroclaw, Poland.

Department of Biochemistry and Immunochemistry, Wroclaw Medical University, 50-367 Wroclaw, Poland.

出版信息

Biomedicines. 2022 Dec 15;10(12):3259. doi: 10.3390/biomedicines10123259.

Abstract

The most effective way to stop the spread of COVID-19 (coronavirus disease 2019) is to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and isolate those infected as soon as possible. More than 1000 types of molecular and antigen-based immunoassay tests to detect SARS-CoV-2 are now commercially available worldwide. In this review, we present the possibilities of molecular diagnostics available in Poland in 2022. We provide a description of what samples have proven useful to confirm SARS-CoV-2 infection, we describe what methods are used, as well as what safeguards can and should be used to prevent false-negative and false-positive results, and finally we review the products that diagnostic laboratories have to choose from. We also describe diagnostic problems associated with the mutation of the virus.

摘要

阻止2019冠状病毒病(COVID-19)传播的最有效方法是检测严重急性呼吸综合征冠状病毒2(SARS-CoV-2),并尽快隔离感染者。目前全球有1000多种基于分子和抗原的免疫分析检测方法可用于检测SARS-CoV-2。在本综述中,我们介绍了2022年波兰可用的分子诊断方法。我们描述了哪些样本已被证明对确诊SARS-CoV-2感染有用,我们介绍了所使用的方法,以及可以且应该采取哪些保障措施来防止假阴性和假阳性结果,最后我们综述了诊断实验室可选择的产品。我们还描述了与病毒突变相关的诊断问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d36/9775127/ca0dc51d551c/biomedicines-10-03259-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验